Purchase Order 75N94021P00425
Award Date 5/25/21
Potential Completion Date 7/24/21
Potential Value $21K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Pleasanton, CA 94588, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $22,067.00 firm fixed price purchase order (Contract # 75N94020P00686) to 10X Genomics, Inc. to provide reagents related to COVID-19 research. The award, which does not have a set-aside designation, is in support of the NIDDK's work under the Coronavirus COVID-19 National Interest Action Code. 10X Genomics is a life sciences technology company that specializes in products and services for single-cell and...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $20,879.20 firm-fixed-price purchase order to 10X Genomics, Inc. to provide reagents for combined single-cell transcriptomics analysis of HIV-specific B cells. This contract does not have a set-aside designation. 10X Genomics is a life sciences technology company that specializes in genomic analysis platforms, reagents, instruments, and software for single-cell and spatial analysis applications. They have a...
- This federal contract award was made by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the U.S. Department of Health and Human Services, to the prime contractor 10X Genomics, Inc. The $22,585.50 firm fixed price purchase order is for the acquisition of the Chromium GEM-X Single Cell 5' Kit, which will be used to support NIDDK's research initiatives. 10X Genomics, a life sciences technology company, provides a range of genomic analysis platforms, reagents,...
- This federal contract award to 10X Genomics, Inc., a for-profit life sciences technology company, was made by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract, valued at $24,270.81, is for the acquisition of a Chromium Next GEN Single Cell 3" Kit V3.1 to support the NIDDK's biomedical research efforts. This fixed-price purchase order does not...
- This contract award to 10X Genomics, Inc. (10X Genomics), a life sciences technology company, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases, part of the National Institutes of Health (NIH). The $23,773 firm fixed-price purchase order is for the delivery of 10X Genomics products and services to support biomedical research, including specialized kits for single-cell and spatial analysis techniques, as well as instruments and associated support services. The...
- This $24,011 firm fixed price purchase order was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the U.S. Department of Health and Human Services, to 10X Genomics, Inc. for the acquisition of "NATURAL HISTORY OF FAMILIAL CARCINOID: TUMOR SINGLE CELL ANALYSIS". The contract does not have a set-aside designation and was completed on December 17, 2020. 10X Genomics is a life sciences technology company that specializes in...
- This federal contract award is for the provision of laboratory equipment consumables to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a component of the National Institutes of Health (NIH). The contract was awarded to 10X Genomics, Inc., a biotechnology company specializing in advanced genomic analysis platforms and reagents. The $46,672.00 firm-fixed-price purchase order is set aside for small businesses and has a completion date of September 21, 2026. 10X...
- This federal contract award was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to 10X Genomics, Inc., a biotechnology company specializing in advanced genomic analysis platforms. The $48,160.70 firm fixed-price contract is for the supply of Chromium GEM-X Single Cell 5' Chip Kits v3 to support single-cell RNA sequencing research. The original solicitation was a combined synopsis/solicitation from the Eunice Kennedy Shriver National Institute of Child...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a Blanket Purchase Agreement (BPA) call contract valued at $14,966.50 to 10X Genomics, Inc. on September 29, 2022, with an ultimate completion date of March 31, 2023. Under this firm fixed-price contract, 10X Genomics will deliver Chromium Fixed RNA Kits for human transcriptome analysis (4 reactions x 1 barcode per the quoted specification). The contract carries no set-aside designation and represents a call...
- This federal contract award, valued at $25,192.50, was issued by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), to 10X Genomics, Inc. The contract is for the procurement of Chromium Next GEM Chip G Single Cell Kits, which support single-cell RNA sequencing and other single-cell analysis applications. The original solicitation was a non-competitive pre-solicitation notice, as NIDDK determined that the 10X Genomics...